AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 276: H376-H382, 1999;
0363-6135/99 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hong, K. W.
Right arrow Articles by Lee, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hong, K. W.
Right arrow Articles by Lee, W. S.
Vol. 276, Issue 2, H376-H382, February 1999

Metabolism of cAMP to adenosine: role in vasodilation of rat pial artery in response to hypotension

Ki Whan Hong, Hwa Kyoung Shin, Hyung Hwan Kim, Jae Moon Choi, Byung Yong Rhim, and Won Suk Lee

Department of Pharmacology, College of Medicine, Pusan National University, Pusan 602-739; and Center for Biofunctional Molecules, Pohang University of Science and Technology, Pohang 790-600, Korea

The purpose of this experiment was to examine whether the cAMP-adenosine pathway is implicated in the autoregulatory vasodilation in response to hypotension. Suffusion with cAMP (1-100 µmol/l) or adenosine (0.01-10 µmol/l) caused a sustained vasodilation of the resting pial arteries in a concentration-dependent manner. In contrast, N6,2'-O-dibutyryl-cAMP and 8-bromo-cAMP exerted a weak dilation at high concentration (100 µmol/l). The vasodilation to cAMP (1-100 µmol/l), adenosine (0.01-10 µmol/l), and hypotension was significantly reduced by pretreatment with 3,7-dimethyl-1-propargylxanthine (1 µmol/l), an A2 receptor antagonist, as well as 3-isobutyl-1-methylxanthine (3 µmol/l), an inhibitor of endo- and ectophosphodiesterase, 1,3-dipropyl-8-p-sulfophenylxanthine (100 µmol/l), an inhibitor of ecto-5'-phosphodiesterase, or alpha ,beta -methylene-adenosine 5'-diphosphate (100 µmol/l), an inhibitor of ecto-5'-nucleotidase. However, 8-cyclopentyltheophylline (1 µmol/l), an A1 antagonist, did not elicit a similar response. The increased release of adenosine when the cortical surface was suffused with cAMP (100 µmol/l) was significantly reduced by 3-isobutyl-1-methylxanthine, 1,3-dipropyl-8-p-sulfophenylxanthine, and alpha ,beta -methylene-adenosine 5'-diphosphate (each 100 µmol/l). These results indicate that the cAMP-adenosine pathway as a viable metabolic mechanism is implicated in the production of adenosine in the rat pial artery and contributes to the regulation of vasodilation in response to hypotension.

A1 and A2 receptors; cerebral autoregulation; calcitonin gene-related peptide


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Kousai, R. Mizuno, F. Ikomi, and T. Ohhashi
ATP inhibits pump activity of lymph vessels via adenosine A1 receptor-mediated involvement of NO- and ATP-sensitive K+ channels
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2585 - H2597.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. K. Jackson and Z. Mi
Preglomerular Microcirculation Expresses the cAMP-Adenosine Pathway
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 23 - 28.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. K. Shin, Y. W. Shin, and K. W. Hong
Role of adenosine A2B receptors in vasodilation of rat pial artery and cerebral blood flow autoregulation
Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H339 - H344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online